As of Mar 04
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. The median estimate represents a +171.74% increase from the last price of 7.36.
The current consensus among 2 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.